These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 37736575)

  • 1. Health worker views on pre-treatment loss to follow-up in adults with pulmonary TB in Western Kenya.
    Mulaku MN; Corrie OM; Odero I; Young T; Steingart KR; Ochodo E
    Public Health Action; 2023 Sep; 13(3):77-82. PubMed ID: 37736575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pre-treatment loss to follow-up in adults with pulmonary TB in Kenya.
    Mulaku MN; Ochodo E; Young T; Steingart KR
    Public Health Action; 2024 Mar; 14(1):34-39. PubMed ID: 38798784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Understanding pretreatment loss to follow-up of tuberculosis patients: an explanatory qualitative study in Chennai, India.
    Thomas BE; Suresh C; Lavanya J; Lindsley MM; Galivanche AT; Sellappan S; Ovung S; Aravind A; Lincy S; Raja AL; Kokila S; Javeed B; Arumugam S; Mayer KH; Swaminathan S; Subbaraman R
    BMJ Glob Health; 2020; 5(2):e001974. PubMed ID: 32181000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors contributing to pre-treatment loss to follow-up in adults with pulmonary tuberculosis: a qualitative evidence synthesis of patient and healthcare worker perspectives.
    Mulaku MN; Nyagol B; Owino EJ; Ochodo E; Young T; Steingart KR
    Glob Health Action; 2023 Dec; 16(1):2148355. PubMed ID: 36548521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pretreatment loss to follow-up of tuberculosis patients in Chennai, India: a cohort study with implications for health systems strengthening.
    Thomas BE; Subbaraman R; Sellappan S; Suresh C; Lavanya J; Lincy S; Raja AL; Javeed B; Kokila S; Arumugam S; Swaminathan S; Mayer KH
    BMC Infect Dis; 2018 Mar; 18(1):142. PubMed ID: 29587651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pre-treatment loss to follow-up and treatment delay among bacteriologically-confirmed tuberculosis patients diagnosed in Mandalay Region, Myanmar.
    Htwe KK; Kyaw NTT; Kumar AMV; Kyaw KWY; Oo MM; Thwin T; Saw S; Aung ST
    Trop Med Health; 2019; 47():30. PubMed ID: 31073273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of mobile voice calls on treatment initiation among patients diagnosed with tuberculosis in a tertiary care hospital of Puducherry: A randomized controlled trial.
    Majella MG; Thekkur P; Kumar AM; Chinnakali P; Saka VK; Roy G
    J Postgrad Med; 2021; 67(4):205-212. PubMed ID: 34169923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identifying and Addressing Factors Contributing to Pretreatment Loss to Follow-Up of Tuberculosis Patients Referred for Treatment from Medical Colleges in Pondicherry: An Implementation Research.
    Stalin P; Manikandan M; Antony V; Murugan N; Singh Z; Kisku KH; Purty AJ; Vasudevan K; Cherian J; Babu V; Pajanivel R; Kalaiselvan G
    Indian J Community Med; 2020; 45(1):27-31. PubMed ID: 32029980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Towards a health-enabling working environment - developing and testing interventions to decrease HIV and TB stigma among healthcare workers in the Free State, South Africa: study protocol for a randomised controlled trial.
    Rau A; Wouters E; Engelbrecht M; Masquillier C; Uebel K; Kigozi G; Sommerland N; Janse van Rensburg A
    Trials; 2018 Jul; 19(1):351. PubMed ID: 29973259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Indicators to Ensure Treatment Initiation of All Diagnosed Sputum Positive Pulmonary Tuberculosis Patients under Tuberculosis Control Programme in India.
    Jayabal L; Frederick A; Mehendale S; Banurekha V
    Indian J Community Med; 2017; 42(4):238-241. PubMed ID: 29184327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Barriers to tuberculosis case finding in primary and secondary health facilities in Ghana: perceptions, experiences and practices of healthcare workers.
    Der JB; Grant AD; Grint D; Narh CT; Bonsu F; Bond V
    BMC Health Serv Res; 2022 Mar; 22(1):368. PubMed ID: 35305634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlates of observing and willingness to report stigma towards HIV clients by (TB) health workers in Africa.
    Straetemans M; Bakker MI; Mitchell EMH
    Int J Tuberc Lung Dis; 2017 Nov; 21(11):6-18. PubMed ID: 29025480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tuberculosis treatment management in primary healthcare sectors: a mixed-methods study investigating delivery status and barriers from organisational and patient perspectives.
    Zhou J; Pu J; Wang Q; Zhang R; Liu S; Wang G; Zhang T; Chen Y; Xing W; Liu J; Hu D; Li Y
    BMJ Open; 2022 Apr; 12(4):e053797. PubMed ID: 35443945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Organisational Culture and Mask-Wearing Practices for Tuberculosis Infection Prevention and Control among Health Care Workers in Primary Care Facilities in the Western Cape, South Africa: A Qualitative Study.
    Kallon II; Swartz A; Colvin CJ; MacGregor H; Zwama G; Voce AS; Grant AD; Kielmann K
    Int J Environ Res Public Health; 2021 Nov; 18(22):. PubMed ID: 34831888
    [No Abstract]   [Full Text] [Related]  

  • 15. Continuing professional development for medical, nursing, and midwifery cadres in Malawi, Tanzania and South Africa: A qualitative evaluation.
    Feldacker C; Pintye J; Jacob S; Chung MH; Middleton L; Iliffe J; Kim HN
    PLoS One; 2017; 12(10):e0186074. PubMed ID: 29040303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 'We are not going anywhere': a qualitative study of Kenyan healthcare worker perspectives on adolescent HIV care engagement during the COVID-19 pandemic.
    Enane LA; Apondi E; Liepmann C; Toromo JJ; Omollo M; Bakari S; Scanlon M; Wools-Kaloustian K; Vreeman RC
    BMJ Open; 2022 Mar; 12(3):e055948. PubMed ID: 35354627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. "Life continues": Patient, health care and community care workers perspectives on self-administered treatment for rifampicin-resistant tuberculosis in Khayelitsha, South Africa.
    Mohr E; Snyman L; Mbakaz Z; Caldwell J; DeAzevedo V; Kock Y; Trivino Duran L; Venables E
    PLoS One; 2018; 13(9):e0203888. PubMed ID: 30216368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determinants of tuberculosis infection control-related behaviors among healthcare workers in the country of Georgia.
    Mirtskhulava V; Whitaker JA; Kipiani M; Harris DA; Tabagari N; Owen-Smith AA; Kempker RR; Blumberg HM
    Infect Control Hosp Epidemiol; 2015 May; 36(5):522-8. PubMed ID: 25648218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Provider reported barriers and solutions to improve testing among tuberculosis patients 'eligible for drug susceptibility test': A qualitative study from programmatic setting in India.
    Shewade HD; Kokane AM; Singh AR; Parmar M; Verma M; Desikan P; Khan SN; Kumar AMV
    PLoS One; 2018; 13(4):e0196162. PubMed ID: 29677210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Community-based treatment of multidrug-resistant tuberculosis: early experience and results from Western Kenya.
    Oyieng'o D; Park P; Gardner A; Kisang G; Diero L; Sitienei J; Carter J
    Public Health Action; 2012 Jun; 2(2):38-42. PubMed ID: 26392946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.